Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 3/20 | 0.34 |
| ▸ | NOS1 | P29475 | 3/20 | 0.34 |
| ▸ | NOS2 | P35228 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124168 | 0.94 | GSR (0.53) | GSRDPP7DPP4DPP8DPP9 | |
| SCHEMBL7112527 | 0.94 | GSR (0.53) | GSRDPP7DPP4DPP8DPP9 | |
| Water SCHEMBL28009501 | 0.92 | GSR (0.52) | GSRDPP7DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL27742346 | 0.91 | GSR (0.50) | GSRDPP7DPP4DPP8DPP9 | |
| Lysine SCHEMBL26662018 | 0.88 | GSR (0.67) | GSRCYP1A2CPB2TSHRNOS3 | |
| Lysine SCHEMBL26662021 | 0.88 | GSR (0.67) | GSRCYP1A2CPB2TSHRNOS3 | |
| SCHEMBL20636766 | 0.88 | DPP7 (0.38) | GSRDPP7DPP8DPP9TSHR | |
| SCHEMBL997560 | 0.87 | GSR (0.52) | GSRDPP7DPP4DPP8DPP9 | |
| SCHEMBL29075853 | 0.87 | GSR (0.52) | GSRDPP7DPP4DPP8DPP9 | |
| SCHEMBL1537223 | 0.87 | GSR (0.52) | GSRDPP7DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118727097-B | Stainless steel band for electronic product and preparation process thereof | 江苏甬金金属科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118727097-A | Stainless steel band for electronic product and preparation process thereof | 江苏甬金金属科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-114761377-B | L-ornithine composite salt and preparation method and application thereof | 武汉远大弘元股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117899041-A | Astragaloside effervescent tablet and preparation process and application thereof | 浙江省肿瘤医院 | 2024-04-19 | — | — | CN | claimed |
| CN-116908344-A | Biomarker for lung cancer diagnosis | 浙江医院 | 2023-10-20 | — | — | CN | claimed |
| WO-2023004055-A1 | METABOLIC AND INFLAMMATORY MARKERS FOR CAR-T CELL THERAPY | THE CLEVELAND CLINIC FOUNDATION (US) | 2023-01-26 | — | — | WO | claimed |
| CN-113024394-B | Preparation method of L-ornithine salt | 武汉远大弘元股份有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114761377-A | L-ornithine composite salt and preparation method and application thereof | 武汉远大弘元股份有限公司 | 2022-07-15 | — | — | CN | claimed |
| US-11161802-B2 | L-ornithine phenyl acetate and methods of making thereof | OCERA THERAPEUTICS, INC. (US) | 2021-11-02 | — | — | US | claimed |
| CN-113024394-A | Preparation method of L-ornithine salt | 武汉远大弘元股份有限公司 | 2021-06-25 | — | — | CN | claimed |
| EP-2803721-A2 | RECOMBINANT MICROORGANISM HAVING IMPROVED PUTRESCINE PRODUCING ABILITY AND METHOD FOR PRODUCING PUTRESCINE BY USING SAME | Cj Cheiljedang Corporation (KR) | 2014-11-19 | — | — | EP | claimed |
| WO-2013192129-A1 | GLUCAGON ANALOGS EXHIBITING GIP RECEPTOR ACTIVITY | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-12-27 | — | — | WO | claimed |
| CN-101798275-B | Method for preparing L-ornithine-L aspartate | CHONGQING LYBON PHARM TECH CO LTD | 2012-10-31 | — | — | CN | claimed |
| CN-102747406-A | Magnesium alloy anodic oxidation electrolyte and magnesium alloy surface treatment method | UNIV CHONGQING | 2012-10-24 | — | — | CN | claimed |
| CN-101880240-A | Ornithine and aspartate compound and novel method thereof | MING WANG | 2010-11-10 | — | — | CN | claimed |
| CN-101798275-A | Method for preparing L-ornithine-L aspartate | CHONGQING LYBON PHARM TECH CO LTD | 2010-08-11 | — | — | CN | claimed |
| EP-1044672-B1 | Water-in-oil emulsified cosmetic | SHISEIDO CO LTD (JP) | 2007-03-07 | — | — | EP | claimed |
| US-5869299-A | USING AN ENZYME SYSTEM FROM STREPTOMYCES, PARTICULARLY S. CLAVULIGERUS. | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-02-09 | — | — | US | claimed |
| EP-0673432-A1 | PROCESS FOR PREPARING CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1995-09-27 | — | — | EP | claimed |
| WO-1994012654-A1 | PROCESS FOR PREPARING CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1994-06-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161802-B2 | L-ornithine phenyl acetate and methods of making thereof | OAT, OTC, ODC1 | GSR 1853/4885DPP7 1895/4885DPP4 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.